Filing Details
- Accession Number:
- 0001209191-19-016443
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-03-05 16:17:31
- Reporting Period:
- 2019-03-01
- Accepted Time:
- 2019-03-05 16:17:31
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1131324 | Genomic Health Inc | GHDX | Services-Medical Laboratories (8071) | 770552594 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1337334 | Steven Shak | 301 Penobscot Drive Redwood City CA 94063 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-03-01 | 25,000 | $28.05 | 360,479 | No | 4 | M | Indirect | Held by the Shak Family Trust |
Common Stock | Disposition | 2019-03-01 | 17,578 | $77.08 | 342,901 | No | 4 | S | Indirect | Held by the Shak Family Trust |
Common Stock | Disposition | 2019-03-01 | 7,322 | $77.54 | 335,579 | No | 4 | S | Indirect | Held by the Shak Family Trust |
Common Stock | Disposition | 2019-03-01 | 100 | $78.35 | 335,479 | No | 4 | S | Indirect | Held by the Shak Family Trust |
Common Stock | Acquisiton | 2019-03-04 | 7,500 | $28.05 | 342,979 | No | 4 | M | Indirect | Held by the Shak Family Trust |
Common Stock | Disposition | 2019-03-04 | 1,918 | $74.76 | 341,061 | No | 4 | S | Indirect | Held by the Shak Family Trust |
Common Stock | Disposition | 2019-03-04 | 2,356 | $75.76 | 338,705 | No | 4 | S | Indirect | Held by the Shak Family Trust |
Common Stock | Disposition | 2019-03-04 | 3,026 | $76.59 | 335,679 | No | 4 | S | Indirect | Held by the Shak Family Trust |
Common Stock | Disposition | 2019-03-04 | 200 | $77.82 | 335,479 | No | 4 | S | Indirect | Held by the Shak Family Trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Indirect | Held by the Shak Family Trust |
No | 4 | S | Indirect | Held by the Shak Family Trust |
No | 4 | S | Indirect | Held by the Shak Family Trust |
No | 4 | S | Indirect | Held by the Shak Family Trust |
No | 4 | M | Indirect | Held by the Shak Family Trust |
No | 4 | S | Indirect | Held by the Shak Family Trust |
No | 4 | S | Indirect | Held by the Shak Family Trust |
No | 4 | S | Indirect | Held by the Shak Family Trust |
No | 4 | S | Indirect | Held by the Shak Family Trust |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (right to buy) | Disposition | 2019-03-01 | 25,000 | $0.00 | 25,000 | $28.05 |
Common Stock | Employee Stock Option (right to buy) | Disposition | 2019-03-04 | 7,500 | $0.00 | 7,500 | $28.05 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
7,500 | 2023-01-31 | No | 4 | M | Direct | |
0 | 2023-01-31 | No | 4 | M | Direct |
Footnotes
- Includes an aggregate of 9,210 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
- These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on November 30, 2018.
- Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
- Represents weighted average sale price. Actual sale prices ranged from $76.35 to $77.34.
- Represents weighted average sale price. Actual sale prices ranged from $77.35 to $78.34.
- Represents actual sale price.
- Represents weighted average sale price. Actual sale prices ranged from $74.22 to $75.16.
- Represents weighted average sale price. Actual sale prices ranged from $75.22 to $76.20.
- Represents weighted average sale price. Actual sale prices ranged from $76.23 to $77.09.
- The option became exercisable as to 25% of the shares on January 31, 2014, and became exercisable as to 1/48th of the shares each full month thereafter.